Q1 2020 Akebia Therapeutics Inc Earnings Call Transcript

May 05, 2020 / 12:30PM GMT
Operator

Good morning, ladies and gentlemen, and welcome to Akebia Therapeutics INNO2VATE Top Line Data Readout Call and its First Quarter Financial Results and Business Highlights Conference Call. As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference, Kristen Sheppard.

Kristen K. Sheppard - Akebia Therapeutics, Inc. - VP of IR

Thank you and good morning. My name is Kristen Sheppard, Senior Vice President of Investor Relations at Akebia. Thank you so much for joining us to discuss Akebia's top line data from INNO2VATE, our global Phase III program of our product candidate vadadustat for the treatment of anemia due to chronic kidney disease and adults dialysis dependent patients.

On today's call, we will also discuss Akebia's first quarter 2020 financial results and other recent business highlights. We issued 2 press releases this morning, one containing INNO2VATE's top line data, followed by one containing our financial results and other recent business highlights. Both of these exciting press

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot